The neurosciences clinical trials team is pleased to announce two new clinical trials in Overactive bladder and Alzheimer’s disease. Find out more.
Going from aerospace engineering to eye surgery, Dr. Howard R. Krauss is a surgical neuro-ophthalmologist. Hear him explain what that is and how this specialized skill can help patients with tumors affecting the eye and vision.
Participants go “Over the Edge for Brain Cancer” and rappel down San Diego’s tallest waterfront building to bring new awareness to brain cancer research.
Electrical stimulation therapy may have a big impact on brain health and recovery in patients with mood disorders, dementia and neurodegenerative disorders.
Pacific Neuroscience Institute, the leading enrollment site for the MDNA55 clinical trial for Glioblastoma, is still open and enrolling eligible patients. This innovative phase 2 study is for the minimally invasive convection-enhanced delivery (CED) of a new bioengineered targeted therapeutic, MDNA55, in adults with recurrent or progressive glioblastoma. Read more.
With advancing years, risk of falling increases. Falls are very common and often devastating. Fortunately, they are also often preventable. Find out how.
Adapting to their life changes within a social and supportive structure can be one of the keys leading to older people succeeding in aging gracefully. The value of strong community programs in supporting health and wellbeing in older people cannot be underestimated.
Pacific Neuroscience Institute opens up two new clinical trials this month, one in Essential Tremor and one in Glioblastoma. Find out more about these new trials as well as the other available open neurological studies.
Pacific Neuroscience Institute is very pleased to announce that neuro-oncologist Jose Carrillo, MD, has been named a Physician of Excellence, by the Orange County Medical Association.
The Pacific Movement Disorders Center team is excited to announce that we are one of the sites participating in the PROSPECT trial from Cala Health, a three month study for people who have mild to severe essential tremor. The trial is open for patient enrollment.